Illustrative concept image.

Preparing for launch in New Cairo. Clinical services remain subject to professional, facility and regulatory verification. An inquiry does not confirm treatment availability or an appointment.

Purpose & realistic expectations

PLLA and calcium hydroxylapatite are distinct material categories with product-specific evidence and indications. Some effects develop gradually over weeks to months. Consultation explores texture, volume, treatment areas and the practicality of follow-up.

Assessment & planning

Your consultation reviews medical history, allergies, current medicines, prior procedures and your goals. Examination and product-specific information guide the decision. You can choose to defer treatment.

Precautions & limitations

Nodules, inflammation, infection and vascular injury are possible. These materials cannot be dissolved in the same way as hyaluronic acid fillers. Product selection, injection plane and clinician expertise matter.

Availability & next steps

REVIVE is preparing for launch in New Cairo. Service availability, the responsible professionals and applicable approvals must be confirmed before any appointment or procedure. An inquiry is not an appointment confirmation.

Frequently asked questions

Is this available now?

REVIVE is preparing for launch in New Cairo. Service availability, the responsible professionals and applicable approvals must be confirmed before any appointment or procedure. An inquiry is not an appointment confirmation.

How is suitability decided?

Your consultation reviews medical history, allergies, current medicines, prior procedures and your goals. Examination and product-specific information guide the decision. You can choose to defer treatment.

References & further reading

FDA — Dermal fillers and safety

Content prepared 15 November 2026. Formal medical review pending. No reviewer or approval is implied. This information supports, and does not replace, an individualized clinical consultation.